Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 13, 2005
[Migraine headache and mitochondrial DNA abnormality]Yasutoshi Koga, Povalko NataliyaNihon Rinsho. Japanese Journal of Clinical Medicine|March 7, 2014
[The treatment of mitochondrial disorders, present and future]Yasutoshi KogaRinsho Shinkeigaku = Clinical Neurology|February 10, 2009
[L-arginine therapy on MELAS]Yasutoshi KogaCurrent Opinion in Clinical Nutrition and Metabolic Care|November 7, 2019
Arginine therapy in mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodesMasamichi Ikawa, Nataliya Povalko, Yasutoshi KogaMitochondrion|February 10, 2019
Biomarkers and clinical rating scales for sodium pyruvate therapy in patients with mitochondrial diseaseYasutoshi Koga, Nataliya Povalko, Eisuke Inoue, et al.Brain & Development|June 2, 2015
ADHD-like behavior in a patient with hypothalamic hamartomaKoujyu Katayama, Yushiro Yamashita, Shuichi Yatsuga, et al.Pediatric Neurology|November 3, 2004
Noonan syndrome, moyamoya-like vascular changes, and antiphospholipid syndromeYushiro Yamashita, Akira Kusaga, Yasutoshi Koga, et al.Mitochondrion|December 3, 2014
GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseasesYasunori Fujita, Masafumi Ito, Toshio Kojima, et al.Annals of the New York Academy of Sciences|July 24, 2010
MELAS and L-arginine therapy: pathophysiology of stroke-like episodesYasutoshi Koga, Nataliya Povalko, Junko Nishioka, et al.Biochimica Et Biophysica Acta|September 28, 2011
Molecular pathology of MELAS and L-arginine effectsYasutoshi Koga, Nataliya Povalko, Junko Nishioka, et al.Pageof 5